Invasive cerebral aspergillosis in non-neutropenic patients: A case series from Western India.

[1]  G. Stroffolini,et al.  Risk factors for invasive aspergillosis in ICU patients with COVID-19: current insights and new key elements , 2021, Annals of Intensive Care.

[2]  G. Bohra,et al.  Clinical manifestations, diagnosis, and treatment outcome of CNS aspergillosis: A systematic review of 235 cases. , 2021, Infectious diseases now.

[3]  K. Marr,et al.  Defining Galactomannan Positivity in the Updated EORTC/MSGERC Consensus Definitions of Invasive Fungal Diseases. , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  J. Berger,et al.  CNS fungal infections: A review , 2021, Journal of the Neurological Sciences.

[5]  Shengyuan Yu,et al.  Central nervous system aspergillosis in immunocompetent patients , 2020, Medicine.

[6]  J. Perfect,et al.  Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  M. Miceli Central Nervous System Infections Due to Aspergillus and Other Hyaline Molds , 2019, Journal of fungi.

[8]  O. Lortholary,et al.  Why are so many cases of invasive aspergillosis missed? , 2019, Medical mycology.

[9]  M. Khanna,et al.  CNS aspergilloma mimicking tumors: Review of CNS aspergillus infection imaging characteristics in the immunocompetent population. , 2017, Journal of neuroradiology. Journal de neuroradiologie.

[10]  D. Denning,et al.  Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  J. Dietemann,et al.  Magnetic Resonance Imaging of Cerebral Aspergillosis: Imaging and Pathological Correlations , 2016, PloS one.

[12]  G. Driessen,et al.  Diagnostic Performance of Galactomannan Antigen Testing in Cerebrospinal Fluid , 2015, Journal of Clinical Microbiology.

[13]  S. Tsuji,et al.  Recurrent cerebral aneurysm formation and rupture within a short period due to invasive aspergillosis of the nasal sinus; pathological analysis of the catastrophic clinical course. , 2015, International journal of clinical and experimental pathology.

[14]  Venkatraman Bhat,et al.  Invasive aspergillosis presenting as swelling of the buccal mucosa in an immunocompetent individual. , 2015, Oral surgery, oral medicine, oral pathology and oral radiology.

[15]  T. Madani,et al.  Isolated cerebral aspergillosis in immunocompetent patients. , 2014, World neurosurgery.

[16]  J. Rello,et al.  Cerebral aspergillosis in adult critically ill patients: a descriptive report of 10 patients from the AspICU cohort. , 2014, International journal of antimicrobial agents.

[17]  M. Hoenigl,et al.  Antifungal therapy of aspergillosis of the central nervous system and aspergillus endophthalmitis. , 2013, Current pharmaceutical design.

[18]  S. Antinori,et al.  Aspergillus meningitis: A rare clinical manifestation of central nervous system aspergillosis. Case report and review of 92 cases , 2012, Journal of Infection.

[19]  E. Mylonakis,et al.  Central Nervous System Aspergillosis: A Series of 14 Cases From a General Hospital and Review of 123 Cases From the Literature , 2012, Medicine.

[20]  J. Baddley Clinical risk factors for invasive aspergillosis. , 2011, Medical mycology.

[21]  I. Velasco,et al.  Cerebral vasculitis caused by Aspergillus simulating ischemic stroke in an immunocompetent patient. , 2010, The Journal of emergency medicine.

[22]  Patricia Muñoz,et al.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  R. Jooma,et al.  Craniocerebral aspergillosis in immunocompetent hosts: surgical perspective. , 2007, Neurology India.

[24]  A. Chakrabarti Epidemiology of central nervous system mycoses. , 2007, Neurology India.

[25]  C. Viscoli,et al.  Aspergillus Galactomannan Antigen in the Cerebrospinal Fluid of Bone Marrow Transplant Recipients with Probable Cerebral Aspergillosis , 2002, Journal of Clinical Microbiology.